Category: Pharma Industry

Novartis Offering 340B Refunds on Two Diagnostic Radiopharmaceuticals

October 5, 2023 Tom Mirga, Editor at Large Views

Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.

Drug manufacturer Novartis is offering 340B covered entities refunds on purchases of two imaging agents, partly contingent on whether an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Major Drugmakers Agree to Negotiate Drug Prices with Medicare

October 5, 2023 William Newton, Associate Editor/Senior Writer Views

Judge Michael Newman of the U.S. District Court for the Southern District of Ohio denied a business group's request to pause Medicare negotiations while legal challenges to the IRA play out.

Medicare drug price negotiations will move ahead as planned after major drugmakers agreed to participate and a federal district judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Eisai Adopts 340B Contract Pharmacy Restrictions, Pfizer and GSK Update Their Limits

October 3, 2023 Tom Mirga, Editor at Large Views

Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.

Japanese pharmaceutical manufacturer Eisai will restrict 340B pricing on six drugs when dispensed by hospitals’ contract pharmacies. It is the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie Joins Legal Battle Over Louisiana’s 340B Contract Pharmacy Law

October 3, 2023 William Newton, Associate Editor/Senior Writer Views

Hospital groups urged a federal district court to dismiss drugmaker AbbVie's lawsuit against Lousiana's 340B contract pharmacy law.

Drugmaker AbbVie has sued Louisiana over its 340B contract pharmacy law, joining a series of drug industry suits that challenge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice

September 28, 2023 Tom Mirga, Editor at Large Views

Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.

Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Transparency, Patient Assistance Requirements Needed in 340B, Say Drugmaker-Backed Groups

September 28, 2023 Rich Daly, Editor in Chief Views

Justin Leventhal, a senior policy analyst for the American Consumer Institute, has advocated for more 340B transparency alongside other drugmaker-backed groups.

Amid ongoing congressional legislative proposals to boost transparency and other requirements for 340B hospitals, two advocacy groups that receive drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Try a Range of Responses to Manufacturer 340B Contract Pharmacy Restrictions

September 26, 2023 Rich Daly, Editor in Chief Views

Community health centers are attempting to mitigate the adverse financial effects of manufacturer 340B contract pharmacy restrictions on their organizations, said Colleen Meiman, national policy advisor for State & Regional Associations of Community Health Centers.

Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appeals Court Judges Press Both Sides in Key Hearing on Arkansas 340B Contract Pharmacy Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

Chief Judge Lavenski Smith of the 8th Circuit Court of Appeals and two other federal judges heard highly anticipated oral arguments for PhRMA v. McClain in a case that challenges Arkansas' 340B contract pharmacy law.

Attorneys representing Arkansas and 340B providers sparred with a drug industry lawyer over the constitutionality of Arkansas’ first-in-the-nation 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Teva Ends 340B Contract Pharmacy Restrictions in Arkansas in Response to State Law

September 21, 2023 William Newton, Associate Editor/Senior Writer Views

The final HRSA manufacturer 340B program audit conducted in fiscal year 2023 had no adverse findings for Teva Pharmaceuticals.

Teva Pharmaceuticals this week ended its 340B contract pharmacy restrictions in Arkansas in response to a state law that prevents [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Incyte Becomes 26th Drugmaker to Place Contract Pharmacy Restrictions

September 21, 2023 Rich Daly, Editor in Chief Views

Incyte will no longer allow 340B hospitals to have direct delivery of Opzelura products purchased at the 340B discount price to contract pharmacies.

Drug manufacturer Incyte Corp. this week announced it will become the 26th drug manufacturer to restrict access to 340B pricing when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live